Related Experiment Video
Updated: Feb 3, 2026

Application of Chronic Stimulation to Study Contractile Activity-induced Rat Skeletal Muscle Phenotypic Adaptations
Published on: January 25, 2018
Selective modulator of peroxisome proliferator-activated receptor-α protects propionic acid induced autism-like
1Department of Pharmacology, Amity Institute of Pharmacy, Amity University Uttar Pradesh, India.
Insights
Fenofibrate, a PPAR-α modulator, improved autism spectrum disorder (ASD) symptoms in rats by reducing neuroinflammation and oxidative stress. This study suggests fenofibrate
Area of Science:
- Neuropharmacology
- Autism Spectrum Disorders Research
- Animal Models of Neurological Disorders
Background:
- Autism spectrum disorders (ASD) are complex neurodevelopmental conditions.
- Propionic acid administration in Wistar rats induces autism-related neurobehavioral and neurobiochemical alterations.
- Peroxisome proliferator-activated receptor alpha (PPAR-α) plays a role in neuroinflammation and oxidative stress.
Purpose of the Study:
- To investigate the neuropharmacological effects of fenofibrate, a PPAR-α modulator, on a rat model of ASD.
- To assess fenofibrate's impact on social behavior, repetitive actions, locomotor activity, anxiety, and exploratory behavior.
- To evaluate fenofibrate's influence on oxidative stress and neuroinflammation markers in key brain regions.
Main Methods:
- ASD-like phenotype induced in Wistar rats via postnatal propionic acid administration.
- Treatment with fenofibrate (100 and 200 mg/kg) administered orally from postnatal day 24 to 48.
- Assessment of neurobehavioral parameters (social interaction, repetitive behavior, locomotion, anxiety, exploration) and biochemical markers (oxidative stress, neuroinflammation) in specific brain regions.
Main Results:
- Propionic acid-induced rats exhibited social deficits, repetitive behaviors, hyperactivity, anxiety, and reduced exploration.
- Elevated oxidative stress and neuroinflammation (increased pro-inflammatory cytokines, decreased anti-inflammatory cytokines) were observed in propionic acid-treated rats.
- Fenofibrate treatment significantly ameliorated the behavioral deficits and reduced oxidative stress and neuroinflammation.
Conclusions:
- Fenofibrate demonstrates significant neurobehavioral and neurobiochemical benefits in a rat model of ASD.
- PPAR-α agonism by fenofibrate may offer a therapeutic avenue for managing ASD-related symptoms.
- Further research is warranted to explore fenofibrate's potential clinical application in individuals with ASD.
Aims:
The present study investigated the neuropharmacological role of PPAR-α modulator, fenofibrate in postnatal-propionic acid induced symptomatology related with autism spectrum disorders (ASD) in Wistar rats.
Main Methods:
The propionic acid (250 mg/kg, p.o.) was administered to rats from postnatal 21st day to 23rd day to induce autism-related neurobehavioral and neurobiochemical alterations in rats. Then, rats were treated with fenofibrate (100 mg/kg and 200 mg/kg, orally) from postnatal 24th day till 48th day. The social behavior (three chambers social testing apparatus), repetitive behavior (Y-maze), locomotor activity (actophotometer), anxiety (elevated plus maze) and exploratory behavior (hole board test) were assessed. Biochemically, oxidative stress (thiobarbituric acid reactive species and reduced glutathione level) and neuroinflammation (interleukin-6, tumor necrosis factor-α and interleukin-10) were evaluated in the cerebellum, brainstem and prefrontal cortex of rats.
Key Findings:
Propionic acid-treated rats showed social impairment, repetitive behavior, hyperlocomotion, anxiety and low exploratory activity. Also, these animals showed higher levels of oxidative stress (increased in thiobarbituric acid reactive species and decreased in reduced glutathione level) as well as inflammation (increased in interleukin-6, tumor necrosis factor-α and decreased in interleukin-10) and inflammation in aforementioned brain-regions. Treatment with fenofibrate significantly attenuated the propionic acid induced-social impairment, repetitive behavior, hyperactivity, anxiety and low exploratory activity. Furthermore, fenofibrate also reduced the oxidative stress and neuroinflammation in propionic acid-treated rats.
Significance:
A selective PPAR-α agonist, fenofibrate provides neurobehavioral and neurobiochemical benefits in postnatal-propionic acid induced autism-related phenotype in rats. Thus, fenofibrate may further be studied for its possible benefits in ASD symptoms.
More Related Videos
Related Concept Videos
Peroxisomes and Mitochondria
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...
Peroxisomes
Internal Receptors
Acid-Catalyzed α-Halogenation of Aldehydes and Ketones
In the first step of the mechanism, the acid protonates the carbonyl oxygen resulting in a resonance-stabilized cation, which subsequently loses an α-hydrogen to form an enol tautomer. The C=C bond in an enol is highly nucleophilic because of the electron-donating nature of the –OH group. Consequently, the double bond attacks an electrophilic halogen to form a...
α-Halogenation of Carboxylic Acid Derivatives: Overview
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

